Review
Enzymatic activation of prodrugs by prostate-specific antigen: targeted therapy for metastatic prostate cancer
Affiliations
- PMID: 9619266
Item in Clipboard
Review
Enzymatic activation of prodrugs by prostate-specific antigen: targeted therapy for metastatic prostate cancer
Cancer J Sci Am.
1998 May.
No abstract available
Similar articles
-
[Role of mitoxantrone in the treatment of hormone-independent metastatic cancer of the prostate].Prog Urol. 2002 Feb;12(1 Suppl 2):31-5. Prog Urol. 2002. PMID: 11980025 French. No abstract available.
-
In vitro and in vivo prodrug therapy of prostate cancer using anti-gamma-Sm-scFv/hCPA fusion protein.Prostate. 2006 Jun 1;66(8):858-66. doi: 10.1002/pros.20402. Prostate. 2006. PMID: 16491483
-
Enzymatic activation of a doxorubicin-peptide prodrug by prostate-specific antigen.Cancer Res. 1998 Jun 15;58(12):2537-40. Cancer Res. 1998. PMID: 9635575
-
New strategies for the medical treatment of prostate cancer.BJU Int. 2005 Dec;96 Suppl 2:35-40. doi: 10.1111/j.1464-410X.2005.05945.x. BJU Int. 2005. PMID: 16359437 Review.
-
Prostate cancer cell survival pathways activated by bone metastasis microenvironment.J Musculoskelet Neuronal Interact. 2005 Jun;5(2):135-44. J Musculoskelet Neuronal Interact. 2005. PMID: 15951629 Review.
Cited by
-
A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease.J Natl Cancer Inst. 2007 Mar 7;99(5):376-85. doi: 10.1093/jnci/djk065. J Natl Cancer Inst. 2007. PMID: 17341729 Free PMC article.
-
A history of prostate cancer treatment.Nat Rev Cancer. 2002 May;2(5):389-96. doi: 10.1038/nrc801. Nat Rev Cancer. 2002. PMID: 12044015 Free PMC article. Review.
-
Optimization of an albumin-binding prodrug of Doxorubicin that is cleaved by prostate-specific antigen.ACS Med Chem Lett. 2010 May 26;1(5):234-8. doi: 10.1021/ml100060m. eCollection 2010 Aug 12. ACS Med Chem Lett. 2010. PMID: 24900200 Free PMC article.
-
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours.Br J Cancer. 2016 Apr 26;114(9):986-94. doi: 10.1038/bjc.2016.72. Br J Cancer. 2016. PMID: 27115568 Free PMC article. Clinical Trial.
-
Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy.Biochem Biophys Rep. 2021 Mar 2;26:100966. doi: 10.1016/j.bbrep.2021.100966. eCollection 2021 Jul. Biochem Biophys Rep. 2021. PMID: 33718631 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical